Biologics Concerns Shift From IP To Bioterrorism
Biologic drugs have recently become an intellectual property issue for lawmakers, and now they are being targeted for bioterrorism concerns, with a Republican senator unveiling a bill that aims to prevent...To view the full article, register now.
Already a subscriber? Click here to view full article